linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth
ET Prime
Auto

Maruti has entered the grungy lanes of slowdown. Its own strengths have brought it here.

Maruti’s strong points have been a low-cost structure, popularity among small- and medium-size business owners and first-time buyers, dominance in the entry-level segment, and rural and semi-urban markets. But those assets are proving to be a drag now.
font size
FONT SIZE
save
SAVE
saved
SAVED
Gift this article
rajivghosh
10 Sep 2019 8 Mins Read 7 comments
Maruti Suzuki Alto cars await export at the Adani Ports and Special Economic Zone in Mundra, around 400km from Ahmedabad. Getty Images
Maruti Suzuki Alto cars await export at the Adani Ports and Special Economic Zone in Mundra, around 400km from Ahmedabad.
July: -30.98%. August: -31.57%. September: could be worse The reason: The first seven days of the current month have already seen retail sales of vehicles down 31% compared with the year-ago period, an indication that September may be worse than August. Looks like passenger vehicles are in for an uphill climb ahead, after a bumpy ride in
tough to get growth back on track anytime soon. But when willingness to buy returns Maruti should benefit. But it must look beyond the ageing portfolio, as its competitors have launched a bunch of new models recently. Price increases related to regulatory challenges will continue to be protracted headwind for its value-conscious customers. ( Graphics by Sadhana Saxena)
July: -30.98%. August: -31.57%. September: could be worse The reason: The first seven days of the current month have already seen retail sales of vehicles down 31% compared with the year-ago period, an indication that September may be worse than August. Looks like passenger vehicles are in for an uphill climb ahead, after a bumpy ride in tough to get growth back on track anytime soon. But when willingness to buy returns Maruti should benefit. But it must look beyond the ageing portfolio, as its competitors have launched a bunch of new models recently. Price increases related to regulatory challenges will continue to be protracted headwind for its value-conscious customers. ( Graphics by Sadhana Saxena)

Gift this story

0 article remaining this month.
300 characters remaining

Done, keep sharing

0 Left this month

We have e-mailed a link of this article to your friends. They would be able to access this article 0 times till the link expires.

Sorry, quota exhausted

0 article shares left

You have exhausted your quota of gift article shares for this month. Your limit will be reset on the 1st of next month.

CONTRIBUTORS WHO HAVE COMMENTED ON THIS STORY

test

user Rajiv Ghosh ET Prime, Principal Analyst - Auto

test

user Itesh Dodhi Nangia Advisors LLP, Director

test

user sebi

Current Edition

Inside the big makeover at Dr. Reddy’s: Can Erez Israeli pull it off?
Pharma

Inside the big makeover at Dr. Reddy’s: Can Erez Israeli pull it off?

The largely family-run Dr. Reddy’s Labs has brought in the former Teva executive to helm a company that has been going through a testing time. Starting off with a rejig of its product portfolio, Israeli plans to double down on growth in the home market, apart from the US, China, and Russia, and build a strong pipeline of innovative formulations.

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]